Mintz Levin Health Law Advisory

The Massachusetts Department of Public Health (DPH) recently adopted some of the nation’s most stringent regulations (the “Final Regulations”) restricting the marketing activities of pharmaceutical and medical device manufacturers (“Manufacturers”).1 Mintz Levin summarized the Final Regulations in a Health Law Client Alert entitled “Massachusetts DPH Releases Final Rules for Pharmaceutical and Medical Device Manufacturers’ Conduct.” In response to the tremendous interest in the Final Regulations, this Advisory expands upon our Client Alert and offers information responsive to questions frequently asked by clients.

This Advisory:

*highlights important submissions that Manufacturers must make to DPH by July 1, 2009;

*highlights changes to the Final Regulations in response to public comments on the proposed regulations, dated December 10, 2008 (“Proposed Regulations”); and

*compares, for purposes of example, several key provisions of the Final Regulations to the PhRMA Code on Interactions with Healthcare Professionals (“PhRMA Code”)2 and the AdvaMed Code of Ethics on Interactions with Health Care Professionals (“AdvaMed Code”).3

Please see full advisory for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Administrative Agency Updates, Health Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz Levin - Health Law & Policy Matters | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »